We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · March 10, 2021

Hemodynamic Effects of Sacubitril–Valsartan vs Enalapril in Patients With Heart Failure

Circulation: Heart Failure


Additional Info

Circulation: Heart Failure
Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients With Heart Failure in the EVALUATE-HF Study: Effect Modification by Left Ventricular Ejection Fraction and Sex
Circ Heart Fail 2021 Mar 05;[EPub Ahead of Print], GF Mitchell, SD Solomon, AM Shah, BL Claggett, JC Fang, J Izzo, CA Abbas, AS Desai

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading